Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects
NCT06490991
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Paroxysmal Nocturnal Hemoglobinuria，IgA Nephropathy
Interventions
DRUG:
HRS-5965 tablets；HRS-5965 capsules
Sponsor
Chengdu Suncadia Medicine Co., Ltd.